REGENERON PHARMACEUTICALS, INC.

Q2 2025 13F Holdings

  • Location
    tarrytown, NY
  • Num holdings

    4

  • Value ($000)

    $1,485,003

  • Date Filed
    08/01/2025
  • Form type
    13F-HR
  • CIK
    0000872589
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
ALNY
ALNY

Alnylam Pharmaceuticals, Inc.

COMMON STOCK
02043Q107
$1.45 B
98 %

4,444,445

NTLA
NTLA

Intellia Therapeutics, Inc.

COMMON STOCK
45826J105
$34.73 M
2 %

3,702,995

ACET
ACET

Adicet Bio, Inc.

COMMON STOCK
007002108
$590.59 K
0 %

968,183

ADVM
ADVM

Adverum Biotechnologies, Inc.

COMMON STOCK
00773U207
$388.95 K
0 %

180,909

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 4 of 4